Terms: = Kidney tumors AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Treatment
41 results:
1. First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid tumors.
Yarchoan M; Powderly JD; Bastos BR; Karasic TB; Crysler OV; Munster PN; McKean MA; Emens LA; Saenger YM; Ged Y; Stagg R; Smith S; Whiting CC; Moon A; Prasit P; Jenkins Y; Standifer N; Dubensky TW; Whiting SH; Ulahannan SV
Cancer Res Commun; 2024 Apr; 4(4):1100-1110. PubMed ID: 38551394
[TBL] [Abstract] [Full Text] [Related]
2. Predictive value of SIRI and SII for metastases in RCC: a prospective clinical study.
Arı E; Köseoğlu H; Eroğlu T
BMC Urol; 2024 Jan; 24(1):14. PubMed ID: 38218876
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.
Minami K; Osawa T; Kojima T; Hara T; Eto M; Takeuchi A; Nakai Y; Ueda K; Ozawa M; Uemura M; Ohba K; Tamura K; Shindo T; Nakagomi H; Takahashi A; Anai S; Yokomizo A; Morizane S; Kimura T; Shimazui T; Miyauchi Y; Mitsuzuka K; Hara H; Yoshimura K; Shiina H; Ito YM; Murai S; Nishiyama H; Shinohara N; Kitamura H;
Urol Oncol; 2023 Nov; 41(11):458.e9-458.e19. PubMed ID: 37798145
[TBL] [Abstract] [Full Text] [Related]
4. Novel Targeted Therapies for Renal Cell Carcinoma: Building on the Successes of Vascular Endothelial Growth Factor and mTOR Inhibition.
Saliby RM; Saad E; Labaki C; Xu W; Braun DA; Viswanathan SR; Bakouny Z
Hematol Oncol Clin North Am; 2023 Oct; 37(5):1015-1026. PubMed ID: 37385938
[TBL] [Abstract] [Full Text] [Related]
5. PCGF6/MAX/KDM5D facilitates MAZ/cdk4 axis expression and pRCC progression by hypomethylation of the DNA promoter.
Zhu M; Zhang RN; Zhang H; Qu CB; Zhang XC; Ren LX; Yang Z; Gu JF
Epigenetics Chromatin; 2023 Mar; 16(1):9. PubMed ID: 36890610
[TBL] [Abstract] [Full Text] [Related]
6. SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of cdk4/6 Inhibitors.
Huang Z; Li X; Tang B; Li H; Zhang J; Sun R; Ma J; Pan Y; Yan B; Zhou Y; Ding D; Yan Y; Jimenez R; Orme JJ; Jin X; Yang J; Huang H; Jia Z
Cancer Res; 2023 Mar; 83(6):875-889. PubMed ID: 36637424
[TBL] [Abstract] [Full Text] [Related]
7. AGA induces sub-G1 cell cycle arrest and apoptosis in human colon cancer cells through p53-independent/p53-dependent pathway.
Peng BY; Singh AK; Chan CH; Deng YH; Li PY; Su CW; Wu CY; Deng WP
BMC Cancer; 2023 Jan; 23(1):1. PubMed ID: 36597025
[TBL] [Abstract] [Full Text] [Related]
8. Biochemical and clinical effects of RPS20 expression in renal clear cell carcinoma.
Shen C; Chen Z; Zhang Y; Xu W; Peng R; Jiang J; Zuo W; Fan Y; Zheng B
Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36484407
[TBL] [Abstract] [Full Text] [Related]
9. The RBPJ/DAPK3/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to cdk4/6 inhibitors.
Liu W; Zhang B; Zhang D; Guo F; Ye K; Zhu L; Jin X
Cell Death Dis; 2022 Apr; 13(4):295. PubMed ID: 35368029
[TBL] [Abstract] [Full Text] [Related]
10. Therapeutic potential of cdk4/6 inhibitors in renal cell carcinoma.
Sager RA; Backe SJ; Ahanin E; Smith G; Nsouli I; Woodford MR; Bratslavsky G; Bourboulia D; Mollapour M
Nat Rev Urol; 2022 May; 19(5):305-320. PubMed ID: 35264774
[TBL] [Abstract] [Full Text] [Related]
11. Molecular determinants of response to PD-L1 blockade across tumor types.
Banchereau R; Leng N; Zill O; Sokol E; Liu G; Pavlick D; Maund S; Liu LF; Kadel E; Baldwin N; Jhunjhunwala S; Nickles D; Assaf ZJ; Bower D; Patil N; McCleland M; Shames D; Molinero L; Huseni M; Sanjabi S; Cummings C; Mellman I; Mariathasan S; Hegde P; Powles T
Nat Commun; 2021 Jun; 12(1):3969. PubMed ID: 34172722
[TBL] [Abstract] [Full Text] [Related]
12. Purification of a novel protein with cytotoxicity against non-small-cell lung cancer cells from Boletus bicolor.
Zhang MH; Zhou R; Liu F; Ng TB
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100135. PubMed ID: 34076300
[TBL] [Abstract] [Full Text] [Related]
13. Mutant CDKN2A regulates P16/p14 expression by alternative splicing in renal cell carcinoma metastasis.
Sun Q; Chen S; Hou Y; Wen X; Teng X; Zhang H; Lai C; Lai M
Pathol Res Pract; 2021 Jul; 223():153453. PubMed ID: 34022680
[TBL] [Abstract] [Full Text] [Related]
14. Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical
Weidle UH; Nopora A
Cancer Genomics Proteomics; 2021; 18(3 Suppl):349-368. PubMed ID: 33994361
[TBL] [Abstract] [Full Text] [Related]
15. Ribociclib induced acute kidney injury: A case report.
Gulturk I; Yilmaz M; Ozmen A; Tacar SY; Erdal GS; Tural D
J Oncol Pharm Pract; 2021 Dec; 27(8):2023-2026. PubMed ID: 33847193
[TBL] [Abstract] [Full Text] [Related]
16. Positively Charged Nanoparticle Delivery of n-Butylidenephthalide Enhances Antitumor Effect in Hepatocellular Carcinoma.
Chang KF; Huang XF; Lin YL; Liao KW; Hsieh MC; Chang JT; Tsai NM
Biomed Res Int; 2021; 2021():8817875. PubMed ID: 33791383
[TBL] [Abstract] [Full Text] [Related]
17. Ribociclib Population Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Analysis of Neutrophils in Cancer Patients.
Lu Y; Yang S; Ho YY; Ji Y
J Clin Pharmacol; 2021 Aug; 61(8):1054-1068. PubMed ID: 33713359
[TBL] [Abstract] [Full Text] [Related]
18. Robotic-assisted Partial Nephrectomy for "Very Small" (<2 cm) Renal Mass: Results of a Multicenter Contemporary Cohort.
Carbonara U; Simone G; Minervini A; Sundaram CP; Larcher A; Lee J; Checcucci E; Fiori C; Patel D; Meagher M; Crocerossa F; Veccia A; Hampton LJ; Ditonno P; Battaglia M; Brassetti A; Bove A; Mari A; Campi R; Carini M; Sulek J; Montorsi F; Capitanio U; Eun D; Porpiglia F; Derweesh I; Autorino R
Eur Urol Focus; 2021 Sep; 7(5):1115-1120. PubMed ID: 33153954
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of the cdk4/6-Cyclin D-Rb Pathway by Ribociclib Augments Chemotherapy and Immunotherapy in Renal Cell Carcinoma.
Chen D; Sun X; Zhang X; Cao J
Biomed Res Int; 2020; 2020():9525207. PubMed ID: 32626773
[TBL] [Abstract] [Full Text] [Related]
20. Esculetin inhibits proliferation, migration, and invasion of clear cell renal cell carcinoma cells.
Duan J; Shi J; Ma X; Xuan Y; Li P; Wang H; Fan Y; Gong H; Wang L; Pang Y; Pang S; Yan Y
Biomed Pharmacother; 2020 May; 125():110031. PubMed ID: 32164951
[TBL] [Abstract] [Full Text] [Related]
[Next]
